Pengiran Anak Puteri Rashidah Sa'adatul Bolkiah Institute of Health Sciences, Universiti Brunei Darussalam, Gadong, BE1410, Brunei Darussalam.
Pengiran Anak Puteri Rashidah Sa'adatul Bolkiah Institute of Health Sciences, Universiti Brunei Darussalam, Gadong, BE1410, Brunei Darussalam; Department of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Surabaya 60115, Indonesia; School of Medical and Life Sciences, Sunway University, Sunway City, Malaysia.
Res Social Adm Pharm. 2023 Jun;19(6):873-881. doi: 10.1016/j.sapharm.2023.02.015. Epub 2023 Mar 1.
Dementia is a disorder that causes a decline of cognitive function, and it affects millions of people worldwide. Increased availability of medications used to treat dementia will inevitably increase the likelihood of drug-related problems (DRPs).
This systematic review sought to identify DRPs due to medication misadventures, including adverse drug reactions (ADRs), and use of inappropriate medications, among patients with dementia or cognitive impairments.
The included studies were retrieved from the electronic databases PubMed and SCOPUS, and a preprint platform (MedRXiv) which were searched from their inception through August 2022. The English-language publications that reported DRPs among dementia patients were included. The JBI Critical Appraisal Tool for quality assessment was used to evaluate the quality of studies included in the review.
Overall, 746 distinct articles were identified. Fifteen studies met the inclusion criteria and reported the most common DRPs, which comprised medication misadventures (n = 9), such as ADRs, inappropriate prescription use, and potentially inappropriate medication use (n = 6).
This systematic review provides evidence that DRPs are prevalent among dementia patients, particularly the older people. It indicates that medication misadventures such as ADRs and inappropriate drug use, as well as potentially inappropriate medications, are the most prevalent DRPs among older people with dementia. Due to the small number of included studies, however, additional studies are required to improve comprehension about the issue.
痴呆症是一种导致认知功能下降的疾病,影响着全球数百万人。用于治疗痴呆症的药物的可用性增加,不可避免地会增加与药物相关的问题(DRPs)的可能性。
本系统评价旨在确定由于药物误用引起的 DRPs,包括痴呆症或认知障碍患者的药物不良反应(ADRs)和使用不当药物。
从电子数据库 PubMed 和 SCOPUS 以及预印本平台(MedRXiv)检索纳入研究,从成立到 2022 年 8 月进行检索。纳入了报告痴呆症患者 DRPs 的英语出版物。使用 JBI 批判性评估工具评估综述中纳入研究的质量。
总共确定了 746 篇不同的文章。15 项研究符合纳入标准并报告了最常见的 DRPs,包括药物误用(n=9),如 ADRs、不当处方使用和潜在不适当药物使用(n=6)。
本系统评价提供的证据表明,DRPs 在痴呆症患者中很常见,尤其是老年人。它表明,药物误用,如 ADRs 和不适当的药物使用,以及潜在不适当的药物,是痴呆症老年人中最常见的 DRPs。然而,由于纳入的研究数量较少,需要进一步的研究来提高对这一问题的理解。